C. Satish Chandran
Direttore/Membro del Consiglio presso STATERA BIOPHARMA, INC.
Profilo
C.
Satish Chandran is the founder of Nucleonics, Inc. (founded in 2001) and Somahlution LLC (founded in 2010).
At Somahlution LLC, he holds the title of Chief Executive Officer & Director.
Dr. Chandran's current job(s) include being the Chief Executive Officer at Akshaya Bio, Inc. (since 2021), President & Chief Executive Officer at Lays Sciences, and Director at Statera Biopharma, Inc. In the past, Dr. Chandran worked as an Associate Professor at Thomas Jefferson University, a Professor at North Dakota State University (from 2010 to 2012), and as the President, Chief Operating & Technology Officer at Marizyme, Inc. (from 2020 to 2021).
Dr. Chandran obtained a doctorate degree from Memorial University of Newfoundland.
Posizioni attive di C. Satish Chandran
| Società | Posizione | Inizio |
|---|---|---|
| STATERA BIOPHARMA, INC. | Direttore/Membro del Consiglio | 24/02/2022 |
Akshaya Bio, Inc.
 Akshaya Bio, Inc. Pharmaceuticals: MajorHealth Technology Akshaya Bio, Inc. develops therapeutics for infectious diseases and cancer. Its technology Chimigen platform to develop therapeutic vaccines for patients with chronic viral infections as well as prophylactic vaccines to prevent infections. The company was founded by Rajan George and is headquartered in Edmonton, Canada. | Amministratore Delegato | 01/04/2021 |
Somahlution LLC
 Somahlution LLC Medical DistributorsDistribution Services Somahlution LLC provides medical products focused on ischemia reperfusion injury using patented and proprietary technologies. It offers DuraGraft, one time intraoperative vascular graft treatment that maintains endothelial function and structure. The company was founded by Vithalbhai Dhaduk and C. Satish Chandran in 2010 and is headquartered in Jupiter, FL. | Fondatore | 01/01/2010 |
| Lays Sciences | Amministratore Delegato | - |
Precedenti posizioni note di C. Satish Chandran
| Società | Posizione | Fine |
|---|---|---|
| MARIZYME, INC. | Presidente | 02/04/2021 |
| North Dakota State University | Corporate Officer/Principal | 01/01/2012 |
| Thomas Jefferson University | Corporate Officer/Principal | - |
Nucleonics, Inc.
 Nucleonics, Inc. Pharmaceuticals: MajorHealth Technology Nucleonics, Inc. develops RNA interference-based therapeutics. It offers DNA vaccine programs. The company was founded in January 2001 and is headquartered in Horsham, PA. | Fondatore | - |
Formazione di C. Satish Chandran
| Memorial University of Newfoundland | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| MARIZYME, INC. | Health Technology |
| STATERA BIOPHARMA, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Nucleonics, Inc.
Nucleonics, Inc. Pharmaceuticals: MajorHealth Technology Nucleonics, Inc. develops RNA interference-based therapeutics. It offers DNA vaccine programs. The company was founded in January 2001 and is headquartered in Horsham, PA. | Health Technology |
Akshaya Bio, Inc.
Akshaya Bio, Inc. Pharmaceuticals: MajorHealth Technology Akshaya Bio, Inc. develops therapeutics for infectious diseases and cancer. Its technology Chimigen platform to develop therapeutic vaccines for patients with chronic viral infections as well as prophylactic vaccines to prevent infections. The company was founded by Rajan George and is headquartered in Edmonton, Canada. | Health Technology |
Somahlution LLC
Somahlution LLC Medical DistributorsDistribution Services Somahlution LLC provides medical products focused on ischemia reperfusion injury using patented and proprietary technologies. It offers DuraGraft, one time intraoperative vascular graft treatment that maintains endothelial function and structure. The company was founded by Vithalbhai Dhaduk and C. Satish Chandran in 2010 and is headquartered in Jupiter, FL. | Distribution Services |
| Lays Sciences |
- Borsa valori
- Insiders
- C. Satish Chandran
